Clincosm LogoSign in Get a demo

Hematological Malignancies

Showing 26 - 50 of 96
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematological Malignancies Trial in Belgium, Netherlands (Conditioning regimen: TBI + Fludarabine, Conditioning regimen:TLI (8

Completed
Has Results
  • Hematological Malignancies
  • Conditioning regimen: TBI + Fludarabine
  • Conditioning regimen:TLI (8 Gy) + ATG
  • Leuven, Flamish Brabant, Belgium
  • +10 more
Nov 16, 2021

Hematological Malignancies Trial in Boston, Durham (Pasireotide)

Completed
Has Results
  • Hematological Malignancies
  • Boston, Massachusetts
  • +1 more
Oct 19, 2021

Donor-recipient ABO Matching on Haploidentical Stem Cell

Completed
  • Hematological Malignancies
  • Haploidentical Stem Cell Transplantation
  • no intervention
  • Hangzhou, Zhejiang, China
  • +1 more
Oct 22, 2021

Hematological Malignancies Trial in Georgia, Poland, United States (Tenalisib)

Enrolling by invitation
  • Hematological Malignancies
  • San Francisco, California
  • +6 more
Nov 1, 2021

Tissue Microarray of Hematological Malignancies

Active, not recruiting
  • Hematological Malignancies
    • Tampere, Finland
      Tampere Univerisity Hospital
    Sep 30, 2021

    Hematological Malignancies Trial in Beijing, Tianjin (TQB3820 tablets)

    Recruiting
    • Hematological Malignancies
    • TQB3820 tablets
    • Beijing, Beijing, China
    • +1 more
    Sep 18, 2021

    Solid Tumors, Hematological Malignancies Trial in Santa Monica, Whittier, Canton (Belinostat IV)

    Completed
    • Solid Tumors
    • Hematological Malignancies
    • Belinostat IV
    • Santa Monica, California
    • +2 more
    Sep 10, 2021

    Immunogenicity of Covid-19 Vaccination for Hematological

    Active, not recruiting
    • Immunogenicity
    • +3 more
      • Varese, Lombardia, Italy
        UOC Ematologia, ASST Sette Laghi, Osp. Di Circolo e Fondazione M
      Sep 10, 2021

      Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in Milwaukee

      Enrolling by invitation
      • Monoclonal Gammopathy of Undetermined Significance
      • +6 more
        • Milwaukee, Wisconsin
          Aurora Health Care
        Jul 20, 2021

        Hematological Malignancies Trial in Nijmegen (MiHA-loaded PD-L-silenced DC Vaccination)

        Completed
        • Hematological Malignancies
        • MiHA-loaded PD-L-silenced DC Vaccination
        • Nijmegen, Gelderland, Netherlands
          Trialoffice Haematology-Oncology
        Mar 31, 2021

        Hematological Malignancies Trial in Canada, Denmark, United States (KPT-330)

        Completed
        Has Results
        • Hematological Malignancies
        • Tampa, Florida
        • +11 more
        Mar 5, 2021

        Hematological Malignancies Trial in Bologna (Intrabone cord blood infusion)

        Completed
        • Hematological Malignancies
        • Intrabone cord blood infusion
        • Bologna, Italy
          Hematology Institute "L. and A. Seràgnoli", S. Orsola-Malpighi U
        Mar 18, 2021

        Hematological Malignancies Trial in Hangzhou (CAR-T cells)

        Recruiting
        • Hematological Malignancies
        • CAR-T cells
        • Hangzhou, Zhejiang, China
          The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
        Mar 8, 2021

        Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) Trial in Worldwide (NiCord®

        Active, not recruiting
        • Hematological Malignancies
        • +6 more
        • NiCord® (omidubicel)
        • Cord Blood Unit
        • Los Angeles, California
        • +51 more
        Jan 7, 2021

        Occurrence and Concentrations of Ibrutinib and Idelalisib

        Completed
        • Hematological Malignancies
        • Blood samples for pharmacokinetics exploration
        • +7 more
        • Toulouse, France
          Cancer University Institute of Toulouse Oncopole
        Dec 24, 2020

        Hematological Malignancies Trial in France, Germany, Switzerland (Study Part 1: KRP203, Study Part 2: KRP203 lower dose, Study

        Completed
        • Hematological Malignancies
        • Study Part 1: KRP203
        • +2 more
        • Paris, France
        • +7 more
        Dec 9, 2020

        Hematological Malignancies Trial in United States (CBL0137)

        Terminated
        • Hematological Malignancies
        • Whittier, California
        • +3 more
        Dec 8, 2020

        Hematological Malignancies Trial in Hangzhou (NK cells/Combined Monoclonal Antibodies)

        Not yet recruiting
        • Hematological Malignancies
        • NK cells/Combined Monoclonal Antibodies
        • Hangzhou, Zhejiang, China
          The First Affiliated Hospital, College of Medicine, Zhejiang Uni
        Dec 8, 2020

        Infectious Diseases, Hematological Malignancies Trial in Hangzhou (LMP1 CAR T-cells)

        Not yet recruiting
        • Infectious Diseases
        • Hematological Malignancies
        • LMP1 CAR T-cells
        • Hangzhou, Zhejiang, China
          The First Affiliated Hospital，College of Medicine, Zhejiang Univ
        Dec 5, 2020

        Hematological Malignancies, Regulatory T Cell Depletion, Relapse Trial in Creteil (T-reg depleted DLI, Standard DLI)

        Recruiting
        • Hematological Malignancies
        • +2 more
        • T-reg depleted DLI
        • Standard DLI
        • Creteil, France
          Henri Mondor Hospital
        Nov 19, 2020

        Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML) Trial in Worldwide (NiCord®)

        Completed
        Has Results
        • Hematological Malignancies
        • +3 more
        • Los Angeles, California
        • +14 more
        Oct 1, 2020

        Hematological Malignancies, Myelodysplastic Syndrome, Leukemia Trial in Houston (Mycophenolate Mofetil (MMF), Thymoglobulin,

        Terminated
        Has Results
        • Hematological Malignancies
        • +3 more
        • Mycophenolate Mofetil (MMF)
        • +3 more
        • Houston, Texas
          UT MD Anderson Cancer Center
        Sep 1, 2020

        Cord Blood Transplantation With Myeloablative Conditioning and

        Unknown status
        • Cord Blood Transplantation
        • Hematological Malignancies
        • CB transplantation
        • Roma, RM, Italy
          Fondazione Policlinico Universitario A. Gemelli IRCCS
        May 1, 2020

        Hematological Malignancies Trial in Haifa, Jerusalem (Allogeneic MPBC transplantation from matched related donor)

        Unknown status
        • Hematological Malignancies
        • Allogeneic MPBC transplantation from matched related donor
        • Haifa, Israel
        • +1 more
        Nov 24, 2019

        Hematological Malignancies, Leukemia, Lymphoma Trial in Philadelphia (Matched Sibling Allogeneic Transplantation)

        Completed
        Has Results
        • Hematological Malignancies
        • +4 more
        • Matched Sibling Allogeneic Transplantation
        • Philadelphia, Pennsylvania
          Thomas Jefferson University
        Sep 27, 2019